The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | MicrobiomeTrials
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-06-10Est. Completion: 2027-03-31
Enrollment target: 45 participants
Locations
University of Nottingham, Nottingham, United Kingdom, United Kingdom
Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom
Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom